22,23-dihydrobrassicasterol

22,23-dihydrobrassicasterol is a lipid of Sterol Lipids (ST) class. 22,23-dihydrobrassicasterol is associated with abnormalities such as Diabetes, Macular degeneration, Drusen, Systemic disease and Diabetes Mellitus. The involved functions are known as cholesterol metabolism, Synthesis, Intestinal Absorption, Liver function and cholesterol absorption. 22,23-dihydrobrassicasterol often locates in Back and Cell membrane. The associated genes with 22,23-dihydrobrassicasterol are apolipoprotein E-3. The related lipids are Total cholesterol, campesterol, lathosterol, Fatty Acids, Nonesterified and Cholesterol, Dietary.

Cross Reference

Introduction

To understand associated biological information of 22,23-dihydrobrassicasterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 22,23-dihydrobrassicasterol?

22,23-dihydrobrassicasterol is suspected in Diabetes, Macular degeneration, Drusen, Systemic disease, Diabetes Mellitus, Liver diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 22,23-dihydrobrassicasterol

MeSH term MeSH ID Detail
Coronary Disease D003327 70 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hypolipoproteinemias D007009 9 associated lipids
Xanthomatosis D014973 17 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Total 7

PubChem Associated disorders and diseases

What pathways are associated with 22,23-dihydrobrassicasterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 22,23-dihydrobrassicasterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 22,23-dihydrobrassicasterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 22,23-dihydrobrassicasterol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 22,23-dihydrobrassicasterol

Download all related citations
Per page 10 20 50 100 | Total 313
Authors Title Published Journal PubMed Link
Okada K et al. Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease. 2012 Atherosclerosis pmid:22892323
Montserrat-de la Paz S et al. The sterols isolated from Evening Primrose oil modulate the release of proinflammatory mediators. 2012 Phytomedicine pmid:22819447
Kurvinen A et al. Parenteral plant sterols and intestinal failure-associated liver disease in neonates. 2012 J. Pediatr. Gastroenterol. Nutr. pmid:22197940
Lupattelli G et al. Visceral fat positively correlates with cholesterol synthesis in dyslipidaemic patients. 2012 Eur. J. Clin. Invest. pmid:21793822
Lupattelli G et al. Non-cholesterol sterols in different forms of primary hyperlipemias. 2012 Nutr Metab Cardiovasc Dis pmid:20708389
Ito N et al. An ultra performance liquid chromatographic method for determining phytosterol uptake by Caco-2 cells. 2012 Anal. Biochem. pmid:22119071
Lupattelli G et al. Cholesterol metabolism differs after statin therapy according to the type of hyperlipemia. 2012 Life Sci. pmid:22554491
Nes WD Biosynthesis of cholesterol and other sterols. 2011 Chem. Rev. pmid:21902244
Gälman C et al. Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19. 2011 J. Intern. Med. pmid:22003820
Miettinen TA et al. Non-cholesterol sterols in serum and endarterectomized carotid arteries after a short-term plant stanol and sterol ester challenge. 2011 Nutr Metab Cardiovasc Dis pmid:20096545